E-LIB Suche - Ergebnisse für: OZASA, HIROAKI

1

Adjuvant Chemotherapy After Neoadjuvant Therapy and Surgery..:

Miyata, Ryo ; Hamaji, Masatsugu ; Nakakura, Akiyoshi...
Annals of Thoracic Surgery Short Reports. , 2024

2

Detection of a co-mutation in the epidermal growth factor r..:

Yoshida, Hiroshi ; Ozasa, Hiroaki ; Hashimoto, Kentaro...
Current Problems in Cancer: Case Reports. 14 (2024) - p. 100286 , 2024

Link: https://doi.org/10.1016/..

3

Quantitative analysis of interstitial lung abnormalities on..:

Yoneyama, Masahiro ; Matsuo, Yukinori ; Kishi, Noriko...
Radiotherapy and Oncology. 198 (2024) - p. 110408 , 2024

Link: https://doi.org/10.1016/..

4

Soluble immune checkpoint factors reflect exhaustion of ant..:

Hayashi, Hidetoshi ; Chamoto, Kenji ; Hatae, Ryusuke...
Journal of Clinical Investigation. 134 (2024) 7 - p. , 2024

Link: https://doi.org/10.1172/..

5

Immune checkpoint inhibitors in patients with lung cancer h..:

Isobe, Kazutoshi ; Nakamura, Yasuhiko ; Sakamoto, Susumu...
ERJ Open Research. 10 (2024) 2 - p. 00981-2023 , 2024

Link: https://doi.org/10.1183/..

6

Adaptive resistance to lorlatinib via EGFR signaling in ALK..:

Katayama, Yuki ; Yamada, Tadaaki ; Tanimura, Keiko...
npj Precision Oncology. 7 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

7

Author Correction: Survival impact of treatment for chronic..:

Ajimizu, Hitomi ; Ozasa, Hiroaki ; Sato, Susumu...
Scientific Reports. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

8

Outcomes of immune checkpoint inhibitors for postoperative ..:

Yuasa, Itsuki ; Hamaji, Masatsugu ; Ozasa, Hiroaki...
General Thoracic and Cardiovascular Surgery. 71 (2023) 9 - p. 534-541 , 2023

Link: https://doi.org/10.1007/..

9

Usefulness of pro-gastrin-releasing peptide as a predictor ..:

Ueki, Kazuhito ; Matsuo, Yukinori ; Kishi, Noriko...
Journal of Radiation Research. 63 (2022) 4 - p. 636-645 , 2022

Link: https://doi.org/10.1093/..

10

Recurrence patterns and progression-free survival after che..:

Kishi, Noriko ; Matsuo, Yukinori ; Shintani, Takashi...
Journal of Radiation Research. 64 (2022) 1 - p. 142-153 , 2022

Link: https://doi.org/10.1093/..

11

Salvage Surgery After Immune Checkpoint Inhibitors for Adva..:

Nagata, Shunichi ; Hamaji, Masatsugu ; Ozasa, Hiroaki...
Clinical Lung Cancer. 23 (2022) 5 - p. e321-e324 , 2022

Link: https://doi.org/10.1016/..

12

Yes‐associated protein 1 mediates initial cell survival dur..:

Yamazoe, Masatoshi ; Ozasa, Hiroaki ; Tsuji, Takahiro...
Cancer Science. 114 (2022) 2 - p. 546-560 , 2022

Link: https://doi.org/10.1111/..

13

Survival impact of treatment for chronic obstructive pulmon..:

Ajimizu, Hitomi ; Ozasa, Hiroaki ; Sato, Susumu...
Scientific Reports. 11 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

14

PD-L1 polymorphisms predict survival outcomes in advanced n..:

Yoshida, Hironori ; Nomizo, Takashi ; Ozasa, Hiroaki...
European Journal of Cancer. 144 (2021) - p. 317-325 , 2021

Link: https://doi.org/10.1016/..

15

MCL1 inhibition is effective against a subset of small-cell..:

Yasuda, Yuto ; Ozasa, Hiroaki ; Kim, Young Hak...
Cell Death & Disease. 11 (2020) 3 - p. , 2020

Link: https://doi.org/10.1038/..